JNCE

Jounce Therapeutics (JNCE)

Jounce Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:JNCE

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/14	22 : 50	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:JNCE	Jounce Therapeutics Inc
2024/02/03	02 : 28	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/15	20 : 41	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/06	05 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/06	05 : 35	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/05	19 : 09	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/05	19 : 06	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	21 : 40	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 31	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 31	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 30	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 30	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 30	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 29	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	20 : 08	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/05/04	09 : 35	GlobeNewswire Inc.	Jounce Therapeutics Announces Closing of Tender Offer	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/04/29	03 : 48	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:JNCE	Jounce Therapeutics Inc
2023/04/25	06 : 20	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:JNCE	Jounce Therapeutics Inc